These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10871316)

  • 21. Preclinical pharmacology of fiduxosin, a novel alpha(1)-adrenoceptor antagonist with uroselective properties.
    Hancock AA; Buckner SA; Brune ME; Esbenshade TA; Ireland LM; Katwala S; Milicic I; Meyer MD; Kerwin JF; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):478-86. PubMed ID: 11805207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doxazosin treatment causes differential alterations of alpha 1-adrenoceptor subtypes in the rat kidney, heart and aorta.
    Yono M; Foster HE; Shin D; Takahashi W; Pouresmail M; Latifpour J
    Life Sci; 2004 Oct; 75(21):2605-14. PubMed ID: 15363664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change of expression levels of alpha1-adrenoceptor subtypes by administration of alpha1d-adrenoceptor-subtype-selective antagonist naftopidil in benign prostate hyperplasia patients.
    Kojima Y; Sasaki S; Shinoura H; Hayase M; Kubota Y; Hayashi Y; Tsujimoto G; Kohri K
    Prostate; 2007 Sep; 67(12):1285-92. PubMed ID: 17626248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
    Brune ME; Katwala SP; Milicic I; Witte DG; Kerwin JF; Meyer MD; Hancock AA; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):487-94. PubMed ID: 11805208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of α1a and α1d-adrenoceptors in the prostate by administration of subtype selective α1-adrenoceptor antagonist tamsulosin in patients with benign prostatic hyperplasia.
    Kojima Y; Sasaki S; Kubota Y; Imura M; Oda N; Kiniwa M; Hayashi Y; Kohri K
    J Urol; 2011 Oct; 186(4):1530-6. PubMed ID: 21855934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).
    Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3930-4. PubMed ID: 17517507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of alpha 1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction.
    Gu B; Reiter JP; Schwinn DA; Smith MP; Korstanje C; Thor KB; Dolber PC
    J Urol; 2004 Aug; 172(2):758-62. PubMed ID: 15247777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of tamsulosin on hypogastric nerve stimulation-induced intraurethral pressure elevation in male and female dogs under anesthesia.
    Ohtake A; Sato S; Saitoh C; Yuyama H; Sasamata M; Miyata K
    Eur J Pharmacol; 2004 Aug; 497(3):327-34. PubMed ID: 15336951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-NH2-boldine, an antagonist of alpha1A and alpha1B adrenoceptors without affinity for the alpha1D subtype: structural requirements for aporphines at alpha1-adrenoceptor subtypes.
    Ivorra MD; Valiente M; Martínez S; Madrero Y; Noguera MA; Cassels BK; Sobarzo EM; D'Ocon P
    Planta Med; 2005 Oct; 71(10):897-903. PubMed ID: 16254819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.
    Testa R; Guarneri L; Taddei C; Poggesi E; Angelico P; Sartani A; Leonardi A; Gofrit ON; Meretyk S; Caine M
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1237-46. PubMed ID: 8667184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
    Yamada S; Ohkura T; Deguchi Y; Kimura R
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
    Noguchi Y; Ohtake A; Suzuki M; Sasamata M
    Eur J Pharmacol; 2008 Feb; 580(1-2):256-61. PubMed ID: 18078926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization and cross talk of alpha1a- and alpha1b-adrenoceptors coexpressed in human embryonic kidney 293 cells.
    Israilova M; Tanaka T; Suzuki F; Morishima S; Muramatsu I
    J Pharmacol Exp Ther; 2004 Apr; 309(1):259-66. PubMed ID: 14722320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
    Kobayashi S; Tomiyama Y; Tatemichi S; Hoyano Y; Kobayashi M; Yamazaki Y
    Eur J Pharmacol; 2009 Jun; 613(1-3):135-40. PubMed ID: 19389393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats.
    Palea S; Maiga A; Guilloteau V; Rekik M; Guérard M; Rouget C; Rischmann P; Botto H; Camparo P; Lluel P; Gilles N
    Br J Pharmacol; 2013 Feb; 168(3):618-31. PubMed ID: 23005263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adventitia removal does not modify the alphaID-adrenoceptors response in aorta during hypertension and ageing.
    Gómez-Zamudio JH; Villalobos-Molina R
    Auton Autacoid Pharmacol; 2009 Jul; 29(3):117-33. PubMed ID: 19566752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor antagonists.
    Witte DG; Brune ME; Katwala SP; Milicic I; Stolarik D; Hui YH; Marsh KC; Kerwin JF; Meyer MD; Hancock AA
    J Pharmacol Exp Ther; 2002 Feb; 300(2):495-504. PubMed ID: 11805209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.